Miyamoto H - Search Results

1

Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer.

Harada M, Dosaka-Akita H, Miyamoto H, Kuzumaki N, Kawakami Y. Harada M, et al. Among authors: miyamoto h. Cancer. 1992 Jan 1;69(1):72-7. doi: 10.1002/1097-0142(19920101)69:1<72::aid-cncr2820690114>3.0.co;2-a. Cancer. 1992. PMID: 1309311

2

[Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].

Nakabayashi T, Miyamoto H, Fujikane T, Shimizu T, Yasuda S, Akita H, Sakai E, Onodera S, Ohsaki Y, Kawakami Y, et al. Nakabayashi T, et al. Among authors: miyamoto h. Gan To Kagaku Ryoho. 1992 Jan;19(1):61-7. Gan To Kagaku Ryoho. 1992. PMID: 1309633 Clinical Trial. Japanese.

3

[Clinical significance of oncogene product expression in human lung cancer].

Dosaka-Akita H, Harada M, Miyamoto H, Kawakami Y. Dosaka-Akita H, et al. Among authors: miyamoto h. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Aug;30(8):1441-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1331597 Japanese.

4

[Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].

Miyamoto H, Kawakami Y, Arimoto T, Asakawa M, Suzuki A, Fujikane T, Onodera S, Nakabayashi T, Yasuda S, Shimizu T, et al. Miyamoto H, et al. Gan To Kagaku Ryoho. 1991 Jun;18(7):1127-34. Gan To Kagaku Ryoho. 1991. PMID: 1647149 Clinical Trial. Japanese.

5

Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.

Miyamoto H, Harada M, Isobe H, Akita HD, Haneda H, Yamaguchi E, Kuzumaki N, Kawakami Y. Miyamoto H, et al. Cancer Res. 1991 Dec 1;51(23 Pt 1):6346-50. Cancer Res. 1991. PMID: 1657384

6

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.

Isobe H, Miyamoto H, Shimizu T, Haneda H, Hashimoto M, Inoue K, Mizuno S, Kawakami Y. Isobe H, et al. Among authors: miyamoto h. Cancer. 1990 Mar 15;65(6):1391-5. doi: 10.1002/1097-0142(19900315)65:6<1391::aid-cncr2820650624>3.0.co;2-k. Cancer. 1990. PMID: 2155055

7

[Clinical study of multiple primary cancers including lung cancer].

Ishikuro A, Isobe H, Miyamoto H, Katabami M, Harada M, Kawakami Y, Okayasu K, Inoue K. Ishikuro A, et al. Among authors: miyamoto h. Gan No Rinsho. 1989 Nov;35(14):1636-40. Gan No Rinsho. 1989. PMID: 2593230 Japanese.

8

The relationship of clinical classification to ras p21 expression in human non-small cell lung cancer.

Dosaka H, Harada M, Kuzumaki N, Kobayashi H, Miyamoto H, Kawakami Y. Dosaka H, et al. Among authors: miyamoto h. Oncology. 1988;45(5):396-400. doi: 10.1159/000226650. Oncology. 1988. PMID: 2842711

9

[Prognostic significance of the nuclear DNA content of a small adenocarcinoma of the lung].

Isobe H, Shimizu T, Miyamoto H, Kawakami Y, Okayasu K, Hashimoto M, Shimizu M, Endo T, Inoue K, Mizuno S. Isobe H, et al. Among authors: miyamoto h. Gan No Rinsho. 1988 Oct;34(12):1667-71. Gan No Rinsho. 1988. PMID: 3193611 Japanese.

10

Immunohistochemical analysis of human lung cancers with anti-ras p21 monoclonal antibodies.

Dosaka H, Harada M, Kuzumaki N, Kobayashi H, Isobe H, Miyamoto H, Kawakami Y. Dosaka H, et al. Among authors: miyamoto h. Int J Biol Markers. 1987 May-Aug;2(2):75-82. doi: 10.1177/172460088700200204. Int J Biol Markers. 1987. PMID: 3330557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,879 results

Search Page